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Background: Warfarin is the oral anticoagulant that is most commonly used to control
and prevent thromboembolic disorders. It requires meticulous testing and dosing
adjustments to attain therapeutic international normalized ratio (INR) levels. Patient selftesting (PST) is associated with a reduced risk of all-cause mortality and lower rates of
thromboembolism and bleeding. PST meters offers convenience and promotes selfinitiative of care.
Purpose: The purpose of the project is to evaluate the effectiveness of INR PST in adult
patients diagnosed with atrial fibrillation, deep vein thrombosis, and mechanical heart
valve on warfarin therapy in a Cardiology practice compared to traditional laboratory
methods, or usual care.
Description of Design: Chart reviews were conducted to identify patients on warfarin
(for greater than six months) with the medical indication of atrial fibrillation, deep vein
thrombosis, and mechanical heart valve. Data obtained from medical records included
INR lab values, age, gender, medical indication, method of testing, and insurance carrier.
INR lab values were analyzed over a four-year time period (August 2010 – August 2014)
for control of INRs based on method of testing.
Outcomes: Pre- and post- data reveal patients had tighter INR control after PST
initiation. A statistically significant trend is noted at the three-month point from date of
initiation, where the group experienced less therapeutic control, however control of INRs
continued to be tighter compared to usual care.
Statement of Conclusions: The data suggests adult patients on warfarin utilizing PST
method of INR testing showed tighter control of INRs as compared to usual care.
Implications for practice: Based on the data obtained, the six months following the
three month PST initiation suggested provider follow-up after three months of initiation
to re-evaluate testing frequency and goals.
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Background & Evidence for problem
Warfarin is the oral anticoagulant that is most commonly used to control and
prevent thromboembolic disorders. According to the Joint Commission improper
monitoring of anticoagulants resulted in loss of function and deaths in 26% of the nation.
Warfarin is a medication that requires meticulous testing and dosing adjustments to attain
therapeutic International Normalized Ration (INR) levels. An INR level is a crucial
laboratory measurement to make certain the blood will not put the patient at risk for
bleeding or clotting. The goal of warfarin management is to administer a therapeutic dose
to provide the patient protection against clotting conditions and minimizing the risk of
bleeding. Signs of warfarin overtreatment are increased bruising, excessive bleeding, and
presence of blood in stool and emesis. The increase danger of bleeding further
complicates safety awareness in older patients. Under treatment may increase the risk for
blood clots, which may dislodge into small arteries in the brain or heart causing stroke or
myocardial infarction. Challenges of usual laboratory testing are time and scheduling
inconveniences, separate visits for blood draw and result interpretation, possible return to
the lab for system error, therefore possible delay in treatment, multiple medical
consultations, and lack of independence.
The main challenge observed in this cardiology practice has been an increase of
patients on warfarin who have acquired complications from non-therapeutic INR’s and
required immediate intervention including hospitalization.
Evidence-based intervention
The intended population in this a cardiology clinic are adults who are currently
receiving warfarin management. The utilization of patient-self testing (PST) is the
planned intervention to maintain a therapeutic INR. Evidence discussed has shown PST
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is just as accurate as conventional laboratory methods (Garcia-Alamino et al., 2012). The
PST is a portable device allowing convenience of INR testing in the comfort of the
patients’ own home. The meter is very similar to glucometers used for diabetic patients.
A sample of blood is collected from a fingerstick using a lancet. The test strip is inserted
into the pocket-sized device and blood is dropped on to the strip. The result is available
immediately. The device works by measuring thromboplastin-mediated clotting time,
then converted to plasma PT and expressed as an INR value. The health care provider
will receive the INR reports from the meter vendor providing PST service as results
become available.
PST would allow for more frequent monitoring, better treatment adherence, and
fewer thromboembolic or hemorrhagic complications (Heneghan, 2012). An estimated
19,380 strokes and 916 bleeds would be prevented each year by home INR testing (Caro,
2004). “A conservative economic model estimated a Medicare savings of $1.14 billion
annually through maintaining patients eligible for anticoagulation on therapeutic doses of
warfarin” (Caro, 2004).
Evidence of Accuracy in Patient Care Settings
There is strong evidence that PST meters are just as accurate as laboratory
findings and are effective to utilize in practice. In a systematic review by Christensen &
Larsen (2012), analyzing 22 randomized control studies, PST meters were found to have
adequate precision in the clinical setting. A randomized control trial conducted by
Sobieral-Teague, Daniel, Farelly, Coghlan, and Gallus monitored daily INR until INRs
were “2.0” for two consecutive readings. The purpose of this study was to determine
correlation of PST meters to laboratory testing. This study compared two point-of-care
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devices from the same manufacturer and compared them to traditional methods. Nearly
all (99.4%) of PST INR’s were within 0.8 units of laboratory INR’s (Sobieral-Teague,
Daniel, Farelly, Coghlan, & Gallus, 2009).
In another randomized control trial study performed by Donaldson, Sullivan, and
Norbeck in 2010, two point-of-care devices were compared with laboratory methods.
INR’S of 52 patients receiving oral Warfarin therapy were measured using both devices
and during the same visit a blood sample was taken from each patient for lab analysis.
Values from PST meters and laboratory were within 0.4 units of each other 67% of the
time (Donaldson, Sullivan, & Norbeck, 2010).
Bardacki et al. studied 105 patients undergoing open-heart surgery for mechanical
valve replacements. Patients were placed on vitamin k antagonists along with low
molecular weight heparin. Patient-self test and laboratory techniques were used to obtain
INR results daily after surgery until therapeutic INR range was achieved. INR values
correlated strongly with lab methods by the 2nd and 5th postoperative days (Bardaki et al.,
2013). Testing occurred daily, using both methods and resulted in similar results.
Evidence of Improved INR Maintenance and Reductions in Bleeding Complications
A systematic review evaluated by Garcia-Alamino et al. (2012) examined effects
of self-monitoring and self-management of oral anticoagulant therapy and compared
results to standard monitoring. The Cochran Central Register of Controlled Trials,
MEDLINE, EMBASE, and CINAHL were databases used to search for 18 randomized
trials, incorporating a total of 4,723 participants. Twelve out of 18 trials reported
improvement in percentage of mean INR measurements in therapeutic range (GarciaAlamino, et al., 2012). “Trials of self-mangement using CoaguChek meters showed
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significant reductions in thromboembolic events and all-cause mortalty; reduced major
hemorrhages” (Garcia-Alamino, et al., 2012, p.2).
Heneghan et al. completed a large meta-analysis of 11 randomized control trials
consists of 6,417 adults and analyzed the effect of self-monitoring or self-management
versus standard monitoring on thromboembolic events, major bleeding, and mortality as
well as measurements within therapeutic range. Searches were limited to EMBASE
(1980-2009) and MEDLINE (1966-2009). The review indicated a 55% reduction in
thromboembolic events, 35% reduction in bleeding, and a 39% reduction in all-cause
mortality (Heneghan, Ward, Perera, & the Self-monitoring Trial Collaboration, 2012).
Heneghan et al. also found improvements on INR measurements within therapeutic range
in patients that were self-monitoring.
Implementation
The purpose of the project is to evaluate the effectiveness of INR PST in adult
patients diagnosed with atrial fibrillation, deep vein thrombosis, and mechanical heart
valve on warfarin therapy in a Cardiology practice compared to traditional laboratory
methods, or usual care. The selection of patients to participate in this study was provided
by the practice and gathered by a computer generated list using the ICD-9 code for
patients on anticoagulant therapy. Data were obtained from two groups of patients on oral
warfarin: 1) patients testing INR’s levels via usual care and 2) patients currently utilizing
PST meters. The practice had 13 patients on PST meters. Inclusion criteria include
warfarin therapy for six months or longer, diagnosis of atrial fibrillation, mechanical
heart valve, and/or history of deep vein thrombosis. All data were obtained from medical
records. Data obtained from the patients’ medical records, over a four-year time period
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(August 2010-Agust 2014), including INR lab values, age, gender, medical indication,
method of testing, and insurance carrier.
Although 4 years of data was collected, three phases of PST monitoring were
identified. The three phases of PST monitoring that were closely evaluated were: six
months prior to initiation of PST, the first three months of initiation of PST, and the last
six months following the three month initiation. All INR data were documented into the
patient chart, regardless of testing method, either usual care or PST meters.
Evaluation Results

Figure 1. Average INR Values Pre- Post- PST
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Figure 2. Consistency of INR values Pre- Post- PST
The PST patient population included 13 patients, 10 over the age of 65 with ten
male patients and three female patients. There were eight patients with the diagnosis
atrial fibrillation (afib), two patients with diagnosis of deep vein thrombosis (DVT), one
patient with both afib and DVT, and two with mechanical heart valves.
INR lab values were analyzed over a four-year time period (August 2010 –
August 2014) for control of INRs based on method of testing. A X bar (Figure 1) and R
(Figure 2) control chart were created using QI Macros software to evaluate the INR
values over the total number of patients, thereby controlling for volume. The X bar
indicates INR values averages for the group for the four-year period (August 2010 –
August 2014). The break in values (see red arrows), indicate initiation of PST. The
control limits for the data values before the break have a wider control, which means
there is a high variability and data fluctuation. The control limits after the break or after
11

PST initiation shows a much narrower control, which means data values was less variable
and tighter control of INR levels. However, the data values after the three-month
initiation period (purple arrows) show increase and wider control once again. The PST
group experienced less therapeutic control, however control of INRs continued to be
tighter compared to usual care.
Figure 2 provides information about how consistent the INR values are among the
group. The red data points seen in the R control chart indicate statistically significant,
undesirable trend showing lessening of therapeutic control, or more variation among
values. The red data points are observed outside of the control limits.

Figure 3. PST group’s Pre-Post Implementation Percent in Therapeutic Range
In Figure 3, the PST group, showed excellent control within the first three months
of initiation. After the three-month adjustment period, monitoring was not as frequent and
resulting in less control. One patient was not testing frequently pre-PST and post-PST.
This patient’s data affected the average percent in time of the PST group. For five of the
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patients, their post- PST results were worse than their pre-PST results. The groups’ INR
average percentage in therapeutic range Pre-PST was approximately 53% and Post-PST
was approximately 58%.

Percent in Therapeutic Range
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Figure 3. Percent in therapeutic range of usual care patients.
Patients in the usual care group had unpredictable and varying INR values. There
were no specific patterns observed. INR’s were tested at least monthly. These patients
were in therapeutic range approximately 50% of the time.
Cost Implications
There were no extra costs spent by the practice prior to implementation. Medicare
remains the top insurer for adults in this population. Fortunately, Medicare covers PST
meters for patients, reimburses the practice for the initial PST education prior to
implementation as well as use of PST monitoring monthly (Bloomfield, 2011).
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Conclusions
According to the evidence, PST meters are an effective INR evaluation method
and preventing clotting and bleeding complications from warfarin. The usual care group
showed fluctuations in INR data and exhibited lack of consistency in therapeutic range.
This study revealed tighter control in the PST group after initiation of meters. There was
an undesirable trend observed through data collection after the three-month initiation
period, which suggests need for follow-up intervention.
Implications for Clinical Practice and Sustainability
PST INR testing method is easily sustainable in this practice setting. Appropriate
provider follow-up and support are the foundations of successful patient outcomes for
patient self-testing. This study suggests a three month follow-up visit may be needed to
reinforce testing frequency and compliance. During this visit it is crucial to identify and
correct any possible barriers to testing.
Discussion
New anticoagulants have recently been introduced as an alternative to warfarin.
These medications do not require close monitoring with INR testing, provide
convenience of standard dosing, and have fewer bleeding and stroke risks (Buller et al.,
2013). Examples of these medications are clopidogrel, ticagrelor, rivaroxaban, and
edoxaban.
The Rocket AF trial compared effectiveness of rivaroxaban and warfarin to
prevent stroke or systemic embolism in patients with nonvalvular atrial fibrillation.
Rivaroxaban proved less frequent intracranial and fatal bleeding than warfarin and
appeared to match effectiveness of warfarin in prevention of stroke and embolism (P<
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0.001). Edoxaban is a newer anticoagulant in the same pharmaceutical category. It is
primarily given to prevent venous thromboembolism. In a study by Buller et al.,
Edoxaban resulted in 3.3% rate of recurrent venous thromboembolism while warfarin
resulted in 6.2% recurrence rate.
The PLATO study compared ticagrelor to clopidogrel to determine superiority on
prevention of vascular events and death in patients with an acute coronary syndrome.
The study resulted in a significantly reduced rate of death from vascular causes,
myocardial infarction or stoke without an increase in rate of major bleeding for patients
taking ticagrelor. (CITE)
Warfarin is a sensitive medication that requires meticulous management to
prevent adverse complications. With the development and release of newer anticoagulant
medications, warfarin may be used less. In the meantime, INR monitoring while on
warfarin remains to be a crucial aspect of care. PST meters have been proven to be as
effective as usual care modalities and should be considered with patients on warfarin.
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Background: Warfarin is the oral anticoagulant that is most commonly used to control
and prevent thromboembolic disorders, it requires meticulous testing and dosing
adjustments to attain therapeutic international normalized ratio (INR) levels. High rates
of patients in non-therapeutic INR ranges are generally caused by failure of the provider
to adjust INR doses based on monitoring. Patient self-testing (PST) is associated with a
reduced risk of all-cause mortality and lower rates of thromboembolism and bleeding.
PST meters offers convenience and promotes self-initiative of care.
Purpose: The purpose of the project is to evaluate the effectiveness of INR PST in adult
patients diagnosed with atrial fibrillation, deep vein thrombosis, and mechanical heart
valve on warfarin therapy in a Cardiology practice compared to traditional laboratory
methods, or usual care.
Description of Design: Chart reviews were conducted to identify patients on warfarin
(for greater than six months) in the practice with the medical indication of atrial
fibrillation, deep vein thrombosis, and mechanical heart valve. Data obtained from
medical records included INR lab values, age, gender, medical indication, method of
testing, and insurance carrier. INR lab values were analyzed over a four-year time period
(August 2010 – August 2014) for control of INRs based on method of testing.
Outcomes: Pre- and post- data reveal patients on warfarin had tighter INR control after
PST initiation. A statistically significant trend is noted at the three-month point from date
of initiation, where the group experienced less therapeutic control, however control of
INRs continued to be tighter compared to usual care.
Statement of Conclusions: The data suggests adult patients on warfarin utilizing PST
method of INR testing showed tighter control of INRs as compared to usual care.
Implications for practice: Appropriate provider follow-up and support are the
foundations of successful patient outcomes for patient self-monitoring.
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BACKGROUND

Heneghan et al. also found improvements in INR
measurements within therapeutic range in patients that
were self-monitoring
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TEMPLATE DESIGN © 2008

The purpose of the project is to evaluate the effectiveness of
INR PST in adult patients diagnosed with atrial fibrillation,
deep vein thrombosis, and mechanical heart valve on
warfarin therapy in a Cardiology practice compared to
traditional laboratory methods, or usual care.

AIM/PURPOSE

• Roche Diagnostics estimated 19,380 strokes and 916
bleeds would be prevented each year by PST INR testing
(Roche Diagnostics)

•

• PST has shown:
• 55% reduction in thromboembolic events
• 35% reduction in bleeding
• 39% reduction in all-cause mortality
(Heneghan, Ward, Perera, & the Self-monitoring Trial
Collaboration, 2012)

• Patient-self testing (PST) has shown significant reductions
in thromboembolic events and mortality (Garcia-Alamino,
et al., 2012)

EVIDENCE

• Many of the patients in this setting on Warfarin acquired
complications from non-therapeutic INR and required
immediate intervention

Setting: Adult population, Cardiology Practice

• Deaths have occurred from improper monitoring of
anticoagulants (Joint Commission, 2008)

• Requires meticulous testing and dosing adjustments to attain
therapeutic international normalized ratio (INR) levels

• Warfarin is the most commonly used oral anticoagulant to
prevent thromboembolic disorders

• The PST group, showed excellent control within the first
three months of initiation. After the three-month
adjustment period, monitoring was not as frequent and
affected INR results

• A statistically significant trend is noted at the three-month
point from date of initiation, where the group experienced
less therapeutic control

• Pre- and post- data reveal patients on warfarin had tighter
INR control after PST initiation

RESULTS

• Three phases of PST implementation that were significant
for monitoring:
• Pre- Data: six months of traditional INR values prior to
initiation of PST
• Post- Data: the first three months of initiation of PST
• The last six months following the three month initiation

• Data over a four-year time period (August 2010- August
2014) was obtained

• Data obtained from the patients’ medical records were INR
lab values, age, gender, medical indication, method of
testing, and insurance carrier

EVALUATION METHODS

• INR values (traditional laboratory or PST) were retrieved
by chart reviews for a total of 37 patients

• Inclusion criteria include adult patients on warfarin therapy
for six months or longer, diagnosis of atrial fibrillation,
mechanical heart valve, and/or history of deep vein
thrombosis

• 13 patients identified using PST meters

• 24 patients identified using traditional laboratory methods
(usual care)

• The selection of patients was based on a computer
generated list using the ICD-9 code for anticoagulant
therapy

PRACTICE INNOVATION
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Figure 2. Pre- Post- PST Implementation Percent in
Therapeutic Range. There are 5 patients whose post- PST
data were worse than their Pre- PST data. This is likely due
to lack of monitoring after the three month adustment phase.
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Figure 1. Control chart made with QI Macros on Excel.
(Top Chart). Average INR values Pre- Post- PST
implementation. Control limits (red lines) is wider and more
varied pre- PST . After Initiation, control limits are tighter, then
becomes wide again. The increase width occurs after the three
month adjustment phase.
(Bottom chart).Consistency of INR values Pre- Post- PST
implementation. There are three points (red dots) that exceed
the control limit, indicating statistically significant trend.
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• Converting all patients on Warfarin to PST meters may
improve overall therapeutic control

• Based on this study, re-education at three month point
may necessary to improve compliance and therapeutic
control

IMPLICATIONS OF PRACTICE

• There was an undesirable trend observed through data
collection after the three-month initiation period, which
suggests need for physician intervention.

• Tighter control in the PST group after initiation of meters
was achieved.
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